Journal of Clinical Endocrinology & Metabolism, Vol 64, 364-370, Copyright © 1987 by Endocrine Society

ARTICLES

Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement

SM Gow, G Caldwell, AD Toft, J Seth, AJ Hussey, VM Sweeting and GJ Beckett

This study was undertaken to compare the sensitivity of the thyrotrophs to that of other tissues to T4 treatment in hypothyroid patients. To do so, we measured serum total and free thyroid hormones and TSH, in addition to several serum markers of peripheral tissue response to thyroid status, in 21 hypothyroid patients treated with 50-micrograms increments of T4 to a maximum of 200 micrograms daily (group I) and in 104 clinically euthyroid patients receiving a long term constant replacement dose (group II). In group I patients, dose-dependent increases (P less than 0.05) in serum glutathione S-transferase, sex hormone-binding globulin, and angiotensin-converting enzyme occurred, whereas serum T4-binding globulin, creatine kinase, and creatinine levels decreased (P less than 0.05). In both patient groups, abnormally high levels of glutathione S-transferase, sex hormone-binding globulin, angiotensin-converting enzyme, alanine aminotransferase, and gamma- glutamyl transferase were found in some patients during treatment. One or more of these biochemical abnormalities suggestive of hyperthyroidism occurred in 15 (71%) group I patients and 27 (26%) group II patients. These were associated with an undetectable serum TSH (less than 0.1 microU/ml) and raised free T4 concentrations in 13, and raised free T3, T4, and T3 concentrations in only 8, 6, and 1 group I patients, respectively. In group II patients, they were more closely associated with an undetectable TSH (67%) or raised free T4 (85%) level than with raised concentrations of free T3 (33%), T4 (26%), or T3 (0%). The use of high sensitivity TSH assays will permit more accurate adjustment of T4 replacement and minimize abnormalities in peripheral tissue biochemistry indicative of overtreatment.

This article has been cited by other articles:

				H. F. Escobar-Morreale, J. I. Botella-Carretero, F. E. del Rey, and G. M. de Escobar Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4946 - 4954. [Abstract] [Full Text] [PDF]

				A. D. Toft Thyroid Hormone Replacement -- One Hormone or Two? N. Engl. J. Med., February 11, 1999; 340(6): 468 - 470. [Full Text]

				S. K. G. Grebe, R. R. Cooke, H. C. Ford, J. N. Fagerstrom, D. P. Cordwell, N. A. Lever, G. L. Purdie, and C. M. Feek Treatment of Hypothyroidism with Once Weekly Thyroxine J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 870 - 875. [Abstract] [Full Text] [PDF]